Newsletter | The Genome Center

Welkom op de webpagina van clinical genomics!

Sinds januari 2001 is dit de webpagina van de Sectie Clinical Genomics. 
Uiteraard zijn opmerkingen over deze pagina altijd welkom op het adres van de administrator.

Welcome to the webpage of
clinical genomics!

Since January 2001, this is the web page of the Department of Clinical Genomics. 
Of course, all remarks can be posted to the administrator.


New developments at the Genome Center Maastricht (GCM)2006
The Genome Center is pleased to announce a number of important new developments that will significantly increase our capabilities to support genomics researchers of the UM and azM. Furthermore, due to new investments and increasing demand (package deals) we are able to bring down the costs for most of our activities considerably.

Alma-Grid:A virtual Lab for the Euregio

As cofounder of the Interreg Alma-GRID project (www.alma-grid.eu) the Genome Center will further extend and optimize its infrastructure and stimulate collaborations with sister universities in the Euregion Meuse-Rhine. The alma-grid project aims at establishing a virtual lab and scientific community in this Euregion in order to use expensive, complementary infrastructure and expertise more efficiently and to provide services in the field of genomics, proteomics and bioinfomatics. Investments are being carried out as part of the project in a computer GRID and in software (LIMS). This LIMS of Labvantage (www.labvantage.com) will be the backbone of the project and will facilitate exchanges within the Euregional scientific community. Investigators or laboratories interested to join this initiative or the LIMS application, please feel free to contact us, as we aim to make the scientific community as big and lively as possible.

Sequencing and resequencing
The purchase of a new ABI3730 sequencer due to the joint efforts of university and hospital has increased the sequencing capacity and reduced costs and prices considerably. We are currently automating the entire sequencing pipeline and implementing DNA isolation and pipetting robots to increase sequencing throughput. New software tools, like Mutation Surveyor, for sequence and MLPA analysis allow a much easier and faster interpretation of data.

A major breakthrough has been the implementation of Affymetrix resequencing CHIPs for the mitochondrial DNA (mtDNA). We are currently negotiating to analyze this year about 600 mtDNA CHIPs of €170 each for clinical service and collaborative research.


Protein assays – 96-well luminometer
The GCM has with the support of the research institutes GROW and CARIM purchased a 96-well luminometer to measure bioluminescence (mainly luciferase). The major advantage of a luminometer is its superior sensitivity. A logic extension of transcription profiling work using microarrays includes the functional characterization of promoters that coordinately respond to the particular perturbations that were the focus of the microarray experiment. In such settings it is clear that a higher throughput will spare time and reagents. A medium throughput experiment involving the effect of 500 siRNAs would require less that an hour of measurement time enabling these kind of experiments.



GCM steps into the proteomics field with PamChip kinase profiling
The Genome Center Maastricht has at its disposal a PamStation™ 4, a fully automated 4-array system designed for processing PamChip® 4 Arrays. It is ideal for low to medium sample throughput applications and assay development. The ‘heart’ of PamChip technology is the use of sheets of a micro porous material as the solid support for manufacturing microarrays.   This material contains millions of 0.2 x 60 micron pores in parallel orientation connecting the top and bottom surfaces. Peptides or antibodies or other proteins are pre-coupled to the large internal surfaces of these pores. Samples containing proteins (or nucleic acid target molecules) are actively “pulsed” backwards and forwards through these pores where they interact by modifying or binding the immobilized peptides or proteins. Such “pulsing”, combined with minimization of diffusion distances, means that equilibration of binding is significantly speeded up. The result is that binding is reduced from hours to minutes depending on the application. In general, monitoring of this binding is possible in real-time, which means that kinetic information is gained for each interaction in question. It is possible to generate up to 400 kinetic curves for each array/sample in parallel.  There are two “of the shelve” PamChip kinase profiling arrays available, one with peptide substrates derived from genuine tyrosine phosphorylated proteins and one for serine/threonine phosphorylated proteins. The tyrosine kinase array contains 144 peptide substrates for tyrosine kinases that can be interrogated independently for their phosphorylation status. Samples of pure kinases or extracts containing tyrosine-kinase activity are actively “pulsed” backwards and forwards through the pores of the arrays. These samples, in presence of ATP, phosphorylate the immobilized  peptide substrates. Furthermore, the effect of varying additional parameters (temperature, salt, presence of inhibitory or competing ligands, etc.) can be interrogated in real-time. This enabling technology has several applications in proteomics: both protein profiling (detection of the presence of members of a sub-proteome in a complex mixture) and functional proteomics.


Genotyping- ABI7900HT Taqman for SNP genotyping
The Genome Center has expanded the Genotyping Unit with an ABI7900HT Taqman. This 384-well Real-Time PCR system is suitable for singleplex SNP-assays in 5µl reaction volumes, which leads to a significant reduction of the cost per sample compared to 96-well based systems. The costs of a typical assay is currently estimated at about €0.30 - €0.35 per SNP genotype. Furthermore, over 2 million SNP assays are already available through the website of Applied Biosystems (Taqman SNP Assays). The Taqman assays are designed and produced by Applied Biosystems and contain 2 PCR primers and 2 allele specific probes. Normally, the assays can be delivered within 2 weeks after ordering. Applied Biosystems will give a refund if assays are not functional. The small scale assay contains enough material for about 1500 samples. The ABI7900HT is therefore suited for projects in which a few hundred to thousands of samples have to be genotyped for a limited number of SNPs.


Affymetrix Targeted Genotyping (Megallele)- system
As the only Affymetrix corelab in the Netherlands, the GCM has recently upgraded the Affymetrix platform (http://www.affymetrix.com/) to a Megallele system. This has a large number of advantages. We can now scan 5 µm features, enabling us to analyse the newest generation of GeneChips like the 500.000 SNP chip for whole genome association studies or CGH, the tiling arrays for detailed unbiased chromosomal analysis and the all exon chips (containing all confirmed and predicted exons in the human genome). Furthermore, this upgrade makes it now possible to run and analyse custom SNP-chips (3K, 5K, 10K and 20K) with the Megallele MIP assays developed by Parallele (Targeted Genotyping). It should be clear that this upgrade significantly improves our 'genomics-toolbox' but also, the use of smaller features will lead to reduced costs per data point.


Bioinformatics
Planning a new study or writing a grant, and in need of help for designing your experiment or with statistical issues? Do not hesitate to contact us for advise to insure that you shall be collecting all the proper information to analyze and answer your questions of interest. We are also pleased to collaborate with you if you need any assistance in analyzing the data you have collected.

With respect to the Alma-Grid project (mentioned above), we shall be shortly increasing our computer power from eight processors to a Computer Cluster of more than 25 processors including a super computer with 64GB of memory. This will more than triple our current analysis capacity and allow us to perform analysis of large scale experiments.


Prices and service levels: 
·           ABI BDTv3.1 sequencing chemie: € 32,00 / aliquot (32 µl).
·           Sequencing en Genescan op ABI3100: € 2,00 / sample van 01-01-2006 tot 01-07-2006 en € 1.85 / sample vanaf 01-07-2006 (excl standaarden bij               Genescan).
·           Bioanalyser NANOchip: € 5,00 / sample.
·           Bioanalyser PICOchip: € 5,50 / sample.
·           Pyrosequencing: €1,85 / sample.
·           ABI7900HT: €0.30 - €0.35 per SNP genotype (1500 assay setup)
·           Affymetrix Gene CHIPs: price reduction of up to 25-50% for a number of CHIPs

Three service levels apply to most of our activities:

1. Plug-and-play:                 Only use of equipment, researcher is responsible for the project
2. Complete support:      All/many phases of the project and work are supported or carried out by Genome Center personnel, shared                                  responsibility
3. Scientific Collaborations: Joint projects work, responsibilities and costst are shared.


Contact Information:
Genome Center Maastricht - all activities: Bert Smeets (bert.smeets@molcelb.unimaas.nl)
Transcription Profiling Unit: Torik Ayoubi (torik.ayoubi@gen.unimaas.nl)
Bioinformatics and Genetic Epidemiology Unit: Patrick Lindsey (patrick.lindsey@gen.unimaas.nl)
SNP Genotyping and Sequencing Unit: Rob Janssen (bert.smeets@molcelb.unimaas.nl



For appointments contact: Rosy Engelen (043-3881995) or rosy.engelen@gen.unimaas.nl

July 17, 2006

________________________________________________________________________________________________________________

New developments at the Genome Center Maastricht (GCM) 2005

The Genome Center is pleased to announce a number of important new developments that will significantly increase our capabilities to support genomics researchers of the UM and azM. 

Affymetrix Megallele:

As one of the first Affymetrix corelabs in Europe, the GCM has upgraded the Affymetrix platform (www.affymetrix.com) to a Megallele system. This has a large number of advantages. We can now scan 5 µm features, enabling us to analyse the newest generation of GeneChips like the 500.000 SNP chip for whole genome association studies, the tiling arrays for detailed unbiased chromosomal analysis and the all exon chips (containing all confirmed and predicted exons in the human genome). Furthermore, this upgrade makes it now possible to run and analyse custom SNP-chips (3K, 5K and 10K) with the Megallele MIP assays developed by Parallele (http://www.parallelebio.com/products-services/genotyping-products.html) . It should be clear that this upgrade significantly improves our ‘genomics-toolbox’ but also, the use of smaller features will lead to reduced costs-per datapoint.

Pamgene:

Within the framework of our European Mitocircle project, the GCM has started a scientific collaboration with Pamgene (www.pamgene.com) . Pamgene is known for their flow-though microarray technology, resulting in very fast (< 1 hr) hybridisation times. Pamchip arrays contain up to 400 oligos, peptides, proteins or antibodies of your choice. This makes it an ideal platform for custom studies in the fields of gene-expression, SNP-genotyping or kinase-assays. Pamgene will install a Pamstation4 in our lab, enabling us to analyse up to 28 samples per day.

Contact Information:

Transcription Profiling Unit: Torik Ayoubi (torik.ayoubi@gen.unimaas.nl)

Bioinformatics and Genetic Epidemiology Unit: Patrick Lindsey ( patrick.lindsey@gen.unimaas.nl)

SNP Genotyping and Sequencing Unit: Bert Smeets (bert.smeets@molcelb.unimaas.nl)

Kind regards, 
Bert Smeets
Head of the Genome Center
(bert.smeets@molcelb.unimaas.nl)

______________________________________________________________________________________________________________________ 


Het GenoomCentrum

Het GenoomCentrum is een uitvloeisel van de BOS en is ondergebracht bij de afdeling populatiegenetica. De doelstellingen zijn het opzetten van toonaangevend Genomics-onderzoek binnen de participerende instituten en het, hetzij technisch (methoden, infrastructuur), hetzij inhoudelijk, ondersteunen van onderzoeksgroepen, die Genoom en Populatiegenetisch onderzoek overwegen of uitvoeren.

Opgezet worden:
  • Een microarray-faciliteit voor het zelf spotten en analyseren van DNA-microarrays
    (Hieronder valt het ontwikkelen van technologie, het beheer van cDNA- en oligonucleotidencollecties, het maken van enige standaard micro-arrays en het implementeren van de bioinformatica, die nodig is voor het analyseren en interpreteren van de data)
  • Een faciliteit voor het typeren van genetische polymorfismen
    (Hieronder valt het opzetten van technologie voor SNP-detectie, het opbouwen en beheer van markersets voor genome-scans en het implementeren van de computerondersteuning voor statistisch-genetische data-analyse)
Over de precieze stand van zaken, hoe exact een beroep op het GenoomCentrum kan worden gedaan en wat de voorwaarden en/of kosten zijn, volgt nader bericht. Mocht U vragen hebben dan kan contact worden gezocht met Rob Janssen, Erika Timmer, Bob Vlietinck of Bert Smeets via nummer 81995 (secretariaat Population Genetics, Genomics & Bioinformatics).

The Genome Center

GCM: Reading the book of life in Maastricht

Genomics is an entirely new area in the life sciences, which has emerged since the genomes of man, animals, plants and micro-organisms were completely analysed. Genomics means an unprecedented increase in knowledge of species and individual organisms and the interaction between individual and environment. A broad variety of applications can be anticipated, ranging from individualised diagnostics in health care and the development of new and safe drugs and food, to environmental safety and sustainability. The Genome Center Maastricht (GCM) integrates genomics research and know-how, bioinfomatics and a fully equipped, state-of-the-art infrastructure to create an optimal environment for research and training programmes in genomics and the life sciences. The GCM aims at becoming a leading center in international genomics research within the themes of the research institutes of the University of Maastricht. In addition, the Genome Center will facilitate the introduction of genomics in health care programmes of the academic hospital Maastricht and will provide support to researchers in the Netherlands and the Euregio and within specific international collaborations. The Genome Center deals with 4 topics: gene expression profiling (home-made/commercial), medium- and low-throughput genotyping, sequencing and bioinformatics. The Genome Center is situated in newly built laboratories. About 2 million Euro has already been invested in new equipment for custom-made (Microgrid II spotter, Biorobotics; mouse, 15K cDNA collection, human (22K), rat (6K) and mouse (20K) oligonucleotide collections, Operon; scanner, GMS, will be replaced this year) and commercial (Affymetrix GeneCHIP system) arrays, including appropriate software tools (Biodiscovery package, MAS/microDB/datamining tools, Affymetrix) and databases (Celera) for analysis. For genotyping several platforms are operational (DHPLC, Transgenomic; Snapshot-ABI3100, Applied Biosystems; Taqman, ABI7700, Applied Biosystems; Pyrosequencer, Pyrosequencing AB). Sequencing and microsatellite analysis is performed on 2 ABI3100 (Applied Biosystems) sequencers. Robots (Tecan) and critical equipment for quality control (Bioanalyser, Agilent) are available as well. Staff members, technicians, IT-personnel, medical-investigators, biostatisticians and bioinformaticians are involved in both research projects and service activities for other users.                                                                                                                                                                        


Genome Center Newsletter

February 1, 2001 [MS Word format]
February 1, 2001 [Adobe Acrobat format]

October 3, 2001 [MS Word format]
October 3, 2001 [Adobe Acrobat format]

September 11, 2002 [MS Word format]
September 11, 2002 [Adobe Acrobat format]

June 2, 2003 [MS Word format]
June 2, 2003 [Adobe Acrobat format]

August 21, 2003
[MS Word format]
August 21, 2003 [Adobe Acrobat format]

October 7, 2003 [MS Word format]
October 7, 2003 [Adobe Acrobat format]